ADAM-1: An AI Reasoning and Bioinformatics Model for Alzheimer's Disease Detection and Microbiome-Clinical Data Integration
View abstract on PubMed
Summary
This summary is machine-generated.Alzheimer's Disease Analysis Model Generation 1 (ADAM-1), a large language model framework, improves Alzheimer's disease classification using multimodal data. It shows greater robustness and consistency than traditional methods.
Area Of Science
- Computational biology
- Artificial intelligence in medicine
- Neuroscience
Background
- Alzheimer's disease (AD) diagnosis relies on complex multimodal data.
- Existing analytical models may lack robustness and consistency.
- Integrating diverse data sources is crucial for enhanced AD understanding.
Purpose Of The Study
- To introduce Alzheimer's Disease Analysis Model Generation 1 (ADAM-1), a novel large language model (LLM) framework.
- To leverage multimodal data for improved Alzheimer's disease classification.
- To enhance AD research and diagnostic applications through advanced AI.
Main Methods
- Development of ADAM-1, a multi-agent reasoning LLM framework.
- Integration and analysis of microbiome profiles, clinical datasets, and knowledge bases.
- Comparative evaluation against XGBoost using multimodal human biological data.
Main Results
- ADAM-1 demonstrated a significantly improved mean F1 score compared to XGBoost.
- ADAM-1 exhibited significantly reduced variance, indicating enhanced robustness and consistency.
- The framework effectively contextualizes findings with literature-driven evidence.
Conclusions
- ADAM-1 offers a robust and consistent approach for Alzheimer's disease classification.
- The LLM framework shows potential for broader applications in AD research and diagnostics.
- Future work will expand data modalities and predictive capabilities for disease progression.

